Hematology & Oncology Doctors in Terre Haute, IN Accepting Medicare

9 Hematology & Oncology doctors found. Showing 1 - 9

Dr. Sang Y Huh, MD Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2723 S 7th St, Suite O, Terre Haute, IN 47802 Phone: 812-232-1418    Fax: 812-234-7362

Suresh Kunapareddy, M.D. Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1711 N 6 1/2 St, Ste 200, Terre Haute, IN 47804 Phone: 812-242-3610    Fax: 812-242-3630

Juan J Correa, M.D. Internal Medicine - Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 1711 N 6 1/2 St, Ste 200, Terre Haute, IN 47804 Phone: 812-242-3610    Fax: 812-242-3630

Dr. Chandra Gavva Reddy, M.D. Internal Medicine - Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 3702 S 4th St, Terre Haute, IN 47802 Phone: 812-234-0098    Fax: 812-234-3873

Vani Manyam, MD Internal Medicine - Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 1711 N 6th 1/2 St, Terre Haute, IN 47804 Phone: 812-242-3610    Fax: 812-242-3630

Rafael L Gallardo, M.D. Internal Medicine - Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 1711 N 6 1/2 St, Ste 200, Terre Haute, IN 47804 Phone: 812-242-3610    Fax: 812-242-3630

Melhem Jabbour, M.D. Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2723 S 7th St Ste O, Terre Haute, IN 47802 Phone: 812-232-1418

Dr. Ashis Kumar Chakrabarti, M.D. Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 3702 S 4th St, Terre Haute, IN 47802 Phone: 812-234-0098    Fax: 812-234-3873

Dr. Roberto Cantillo, MD Internal Medicine - Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 6926 Manor Pl, Terre Haute, IN 47802 Phone: 812-299-9447

News Archive

Astellas Pharma extends all-cash tender offer of OSI Pharmaceuticals

Astellas Pharma Inc. announced today that it has extended its all-cash tender offer for $52 per share for all of the currently outstanding shares of common stock (including the associated stock purchase rights) of OSI Pharmaceuticals to 11:59 p.m. New York City time on Friday, April 23, 2010, unless further extended.

Brisk walking may delay or even prevent progression of prostate cancer in men

Men with prostate cancer can improve their outcomes if they walk briskly for at least three hours a week following their diagnosis, according to a recent study in Cancer Research, a journal of the American Association for Cancer Research.

Health premium costs: Hot topic in partisan debate

Just as President Obama and members of his administration assert that health insurance premiums will go down under the health overhaul, GOP lawmakers argue these claims are overstated. Ultimately, how this issue shakes out will be central to the public's perception of the new law.

Findings could lead to new treatment for ALS, dementia

University of Toronto (U of T) researchers are proposing a new way of understanding Amyotrophic Lateral Sclerosis (ALS), the devastating and incurable neurological disease. Their findings, published today in the journal Neuron, could be a major milestone on the path to a treatment for both ALS and dementia.

Research holds promise for developing treatments for retinitis pigmentos

One of the leading causes of inherited blindness in humans, retinitis pigmentosa, is analogous to retinal dystrophies that lead to blindness in dogs. Because of their similarities, identifying gene mutations underlying several types of canine retinal dystrophies has suggested courses for research on RP in humans. These advances are significant for both humans and dogs.

Read more Medical News

› Verified 8 days ago